Severe Progressive Mycobacterium avium Complex Infection Associated With Brentuximab Vedotin Therapy-Reference-Cited by-同舟云学术

Severe Progressive Mycobacterium avium Complex Infection Associated With Brentuximab Vedotin Therapy

Published:2018-11-12 Issue:4 Volume:8 Page:371-373
ISSN:2048-7193
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Mukkada Sheena¹²^ORCID,Metzger Monika L¹²,Santiago Teresa³,Wolf Joshua¹⁴

Affiliation:

1. Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, Tennessee

2. University of Tennessee Health Sciences Center, Memphis, Tennessee

3. Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee

4. Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology, and Child Health

Link

http://academic.oup.com/jpids/article-pdf/8/4/371/30106991/piy109.pdf

Reference6 articles.

1. MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature;Camargo;Clin Infect Dis,2013

2. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review;Prevots;Clin Chest Med,2015

3. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection;Tang;J Immunol,2008

4. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium;Flórido;J Leukoc Biol,2004

5. Clinical and Laboratory Standards Institute. “Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes: Approved Standard —Second Edition”. CLSI document M24-A2,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADRs and ADEs: Focus on drug-antibody conjugates, pharmacogenomics, and COVID19 vaccines;Side Effects of Drugs Annual;2023

2. Infectious Challenges with Novel Antibody–Based Therapies;Current Infectious Disease Reports;2021-05-07

3. Antineoplastics;Reactions Weekly;2020-05